المؤلفون: Crabtree, Thomas S.J., Choudhary, Pratik, Lumb, Alistair, Hammond, Peter, McLay, A., Campbell, Fiona, Ng, Sze M., Wilmot, Emma G., Hussain, Sufyan

المصدر: Crabtree , T S J , Choudhary , P , Lumb , A , Hammond , P , McLay , A , Campbell , F , Ng , S M , Wilmot , E G & Hussain , S 2022 , ' Association of British Clinical Diabetologists, Diabetes Technology Network UK and Association of Children’s Diabetes Clinicians Survey of UK Healthcare Professional Attitudes Towards Open-Source Automated Insulin Delivery Systems ' , Diabetes Therapy , vol. 13 , no. 2 , pp. 341-353 . https://doi.org/10.1007/s13300-022-01203-5Test

مصطلحات موضوعية: Attitudes, Ethics, Healthcare professional opinion, Open-source automated insulin delivery, Technology

الوصف: Introduction: Automated insulin delivery (AID) systems can enable improved glycaemic outcomes with reduced mental burden. Open-source AID (OS-AID) systems overcome some of the developmental and access barriers enabling a wider use of these systems. Limited data are available on healthcare professional (HCP) opinions and current practice regarding these systems. The aim of this survey was to gain insight into HCP perceptions and practices around OS-AID. Methods: This survey was developed collaboratively with OS-AID users and distributed to adult and children’s teams, using an online survey tool. Results were received between February and April 2019. Responses were assessed using simple descriptive statistics with analyses stratified by respondent characteristics. Results: 317 responses were obtained from a range of HCPs in both adult and paediatric services. Key results include: HCP perception of OS-AID as “risky in the wrong hands” (43%); 91% felt uncomfortable initiating discussions around OS-AID because of lack of regulation (67%) and/or their own lack of knowledge (63%). Half of HCPs (47%) reported that they would choose OS-AID if they themselves had type 1 diabetes. Conclusions: HCPs are generally supportive of OS-AID users but many feel uncomfortable with the technicalities of the systems given the lack of approval. Knowledge around the use of these systems was limited. Re-assessment of HCP perceptions should be performed in the future given the evolving landscape of diabetes technology, recent consensus statements and emerging ethical and legal perspectives.

الإتاحة: https://doi.org/10.1007/s13300-022-01203-5Test
https://kclpure.kcl.ac.uk/portal/en/publications/51c9118d-2991-4685-bf0a-f92e3635eb49Test
http://www.scopus.com/inward/record.url?scp=85123908268&partnerID=8YFLogxKTest

المؤلفون: Griffin, Tomás P, Gallen, Geraldine, Hartnell, Sara, Crabtree, Thomas, Holloway, Melissa, Gibb, Fraser W, Lumb, Alistair, Wilmot, Emma G, Choudhary, Pratik, Hussain, Sufyan

المساهمون: Griffin, Tomás P [0000-0003-1625-9394], Gibb, Fraser W [0000-0002-5576-6463], Lumb, Alistair [0000-0001-7041-9534], Choudhary, Pratik [0000-0001-7635-4735], Hussain, Sufyan [0000-0001-6611-8245], Apollo - University of Cambridge Repository

مصطلحات موضوعية: Blood Glucose, Technology, hybrid closed loop, type 1 diabetes, artificial pancreas, Blood Glucose Self-Monitoring, automated insulin delivery systems, insulin pumps, State Medicine, Diabetes Mellitus, Type 1, Insulin Infusion Systems, England, Humans, Hypoglycemic Agents, Insulin, continuous glucose monitoring

الوصف: This best practice guide is written with the aim of providing an overview of current hybrid closed-loop (HCL) systems in use within the United Kingdom's (UK) National Health Service (NHS) and to provide education and advice for their management on both an individual and clinical service level. The environment of diabetes technology, and particularly HCL systems, is rapidly evolving. The past decade has seen unprecedented advances in the development of HCL systems. These systems improve glycaemic outcomes and reduce the burden of treatment for people with type 1 diabetes (pwT1D). It is anticipated that access to these systems will increase in England as a result of updates in National Institute of Health and Care Excellence (NICE) guidance providing broader support for the use of real-time continuous glucose monitoring (CGM) for pwT1D. NICE is currently undertaking multiple-technology appraisal into HCL systems. Based on experience from centres involved in supporting advanced technologies as well as from the recent NHS England HCL pilot, this guide is intended to provide healthcare professionals with UK expert consensus on the best practice for initiation, optimisation and ongoing management of HCL therapy.

وصف الملف: text/xml; application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b93e54f6168864b901636ae678e1563aTest
https://www.repository.cam.ac.uk/handle/1810/348509Test

المؤلفون: Street, Tim, Crabtree, Thomas SJ, Wilmot, Emma G

المصدر: British Journal of Diabetes; Vol. 19 No. 2 (2019): DECEMBER 2019; 136-140 ; 2397-6241 ; 2397-6233

مصطلحات موضوعية: diabetes, technology, do-it-yourself artificial pancreas, patient experience

وصف الملف: application/pdf; text/html

العلاقة: https://bjd-abcd.com/index.php/bjd/article/view/469/681Test; https://bjd-abcd.com/index.php/bjd/article/view/469/683Test; https://bjd-abcd.com/index.php/bjd/article/view/469Test

الإتاحة: https://doi.org/10.15277/bjd.2019.231Test
https://bjd-abcd.com/index.php/bjd/article/view/469Test

المؤلفون: Griffin, Tomás P., Gallen, Geraldine, Hartnell, Sara, Crabtree, Thomas, Holloway, Melissa, Gibb, Fraser W., Lumb, Alistair, Wilmot, Emma G., Choudhary, Pratik, Hussain, Sufyan

المصدر: Diabetic Medicine; Jul2023, Vol. 40 Issue 7, p1-21, 21p

مصطلحات موضوعية: TREATMENT of diabetes, THERAPEUTICS, OCCUPATIONAL roles, REFERENCE values, TEAMS in the workplace, BLOOD sugar monitoring, MEDICAL protocols, LABOR supply, INSULIN pumps, AUTOMATION, HYPOGLYCEMIA, HEALTH care teams, TECHNOLOGY, PHYSICIANS, MEDICAL societies

مصطلحات جغرافية: UNITED Kingdom

مستخلص: This best practice guide is written with the aim of providing an overview of current hybrid closed‐loop (HCL) systems in use within the United Kingdom's (UK) National Health Service (NHS) and to provide education and advice for their management on both an individual and clinical service level. The environment of diabetes technology, and particularly HCL systems, is rapidly evolving. The past decade has seen unprecedented advances in the development of HCL systems. These systems improve glycaemic outcomes and reduce the burden of treatment for people with type 1 diabetes (pwT1D). It is anticipated that access to these systems will increase in England as a result of updates in National Institute of Health and Care Excellence (NICE) guidance providing broader support for the use of real‐time continuous glucose monitoring (CGM) for pwT1D. NICE is currently undertaking multiple‐technology appraisal into HCL systems. Based on experience from centres involved in supporting advanced technologies as well as from the recent NHS England HCL pilot, this guide is intended to provide healthcare professionals with UK expert consensus on the best practice for initiation, optimisation and ongoing management of HCL therapy. [ABSTRACT FROM AUTHOR]

: Copyright of Diabetic Medicine is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

المؤلفون: Crabtree, Thomas S. J., Choudhary, Pratik, Lumb, Alistair, Hammond, Peter, McLay, A., Campbell, Fiona, Ng, Sze M., Wilmot, Emma G., Hussain, Sufyan

المصدر: Diabetes Therapy; Feb2022, Vol. 13 Issue 2, p341-353, 13p

مصطلحات موضوعية: MEDICAL personnel, PROFESSIONALISM, DIABETES in children, TYPE 1 diabetes, INSULIN, INSULIN pumps

مصطلحات جغرافية: UNITED Kingdom

مستخلص: Introduction: Automated insulin delivery (AID) systems can enable improved glycaemic outcomes with reduced mental burden. Open-source AID (OS-AID) systems overcome some of the developmental and access barriers enabling a wider use of these systems. Limited data are available on healthcare professional (HCP) opinions and current practice regarding these systems. The aim of this survey was to gain insight into HCP perceptions and practices around OS-AID. Methods: This survey was developed collaboratively with OS-AID users and distributed to adult and children's teams, using an online survey tool. Results were received between February and April 2019. Responses were assessed using simple descriptive statistics with analyses stratified by respondent characteristics. Results: 317 responses were obtained from a range of HCPs in both adult and paediatric services. Key results include: HCP perception of OS-AID as "risky in the wrong hands" (43%); 91% felt uncomfortable initiating discussions around OS-AID because of lack of regulation (67%) and/or their own lack of knowledge (63%). Half of HCPs (47%) reported that they would choose OS-AID if they themselves had type 1 diabetes. Conclusions: HCPs are generally supportive of OS-AID users but many feel uncomfortable with the technicalities of the systems given the lack of approval. Knowledge around the use of these systems was limited. Re-assessment of HCP perceptions should be performed in the future given the evolving landscape of diabetes technology, recent consensus statements and emerging ethical and legal perspectives. Plain Language Summary: Open-source automated insulin delivery systems are an increasingly encountered diabetes technology. These involve a small glucose sensor and an insulin delivery device called an insulin pump. These two devices interact to allow adjustment of insulin delivery to maintain glucose levels in a desirable range. The computer codes which drive these systems are developed by people with diabetes or their families rather than by device companies; as such, they have not been through formal approval processes and therefore there is limited formal evidence concerning whether they are safe or beneficial to use. Users report high satisfaction with these devices and improvements in their diabetes management. This survey was performed to assess the opinions of UK healthcare professionals and their usual practice. Key results include: UK healthcare professionals would not routinely recommend the use of these devices and there was concern about the medicolegal implications of use. However, UK healthcare professionals were generally supportive of those who chose to use the devices. Interestingly, almost half of the healthcare professionals would use the systems if they had diabetes. [ABSTRACT FROM AUTHOR]

: Copyright of Diabetes Therapy is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)